Is Hims The Next Big Name In Peptides? Shares Recover From Earnings Dive.
Hims stock inched lower Tuesday, recovering from a late-Monday dive, as the telehealth giant seemingly moves closer to the peptide segment. The post Is Hims The Next Big Name In Peptides? Shares Recover From Earnings Dive. appeared first on Investor's Business Daily .
Hims stock inched lower Tuesday, recovering from a late-Monday dive, as the telehealth giant seemingly moves closer to the peptide segment. The post Is Hims The Next Big Name In Peptides? Shares Recover From Earnings Dive. appeared first on Investor's Business Daily .
BELLINGS Intelligence Score: 8
Why it matters
This is a routine market update about a telehealth company’s stock movement and potential product expansion, which does not materially affect credit markets or underwriting standards.
Sources
Investor's Business Daily
Is Hims The Next Big Name In Peptides? Shares Recover From Earnings Dive.
Hims stock inched lower Tuesday, recovering from a late-Monday dive, as the telehealth giant seemingly moves closer to the peptide segment. The post Is Hims The Next Big Name In Peptides? Shares Recover From Earnings Dive. appeared first on Investor's Business Daily .